Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hsfy2
|
ENSMUSG00000045336.4 | heat shock transcription factor, Y-linked 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_56795009_56795543 | Hsfy2 | 157841 | 0.035987 | 0.23 | 7.3e-02 | Click! |
chr1_56743610_56743761 | Hsfy2 | 106250 | 0.071763 | -0.02 | 8.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_78771411_78771855 | 6.39 |
Gm47209 |
predicted gene, 47209 |
2912 |
0.24 |
chr14_101839786_101841002 | 5.62 |
Lmo7 |
LIM domain only 7 |
97 |
0.98 |
chr14_20667325_20668286 | 4.88 |
Synpo2l |
synaptopodin 2-like |
501 |
0.59 |
chr18_10785293_10785854 | 4.69 |
Mir1a-2 |
microRNA 1a-2 |
21 |
0.55 |
chr14_101841178_101841822 | 4.60 |
Lmo7 |
LIM domain only 7 |
681 |
0.79 |
chr8_45886449_45886624 | 4.10 |
Pdlim3 |
PDZ and LIM domain 3 |
1016 |
0.44 |
chr16_55820192_55820446 | 3.92 |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
1804 |
0.33 |
chr11_103102696_103105788 | 3.91 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr16_49857400_49857908 | 3.90 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
1867 |
0.46 |
chr1_149960555_149961570 | 3.87 |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
193 |
0.96 |
chr6_135362982_135365483 | 3.81 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chr18_34623709_34624000 | 3.80 |
Brd8 |
bromodomain containing 8 |
699 |
0.38 |
chr19_36117188_36117519 | 3.77 |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
2557 |
0.28 |
chr3_138067510_138069146 | 3.75 |
Gm5105 |
predicted gene 5105 |
940 |
0.46 |
chr18_77806634_77806803 | 3.73 |
F830208F22Rik |
RIKEN cDNA F830208F22 gene |
9975 |
0.15 |
chr13_109687562_109688031 | 3.73 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
1620 |
0.56 |
chr5_119836883_119837654 | 3.72 |
Tbx5 |
T-box 5 |
1113 |
0.47 |
chr18_82855333_82855721 | 3.68 |
4930445N18Rik |
RIKEN cDNA 4930445N18 gene |
367 |
0.85 |
chr15_85297584_85298676 | 3.54 |
Fbln1 |
fibulin 1 |
34676 |
0.14 |
chr6_54971542_54971693 | 3.53 |
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
44 |
0.97 |
chr18_10786870_10787338 | 3.52 |
Mir133a-1hg |
Mir133a-1, Mir1b and Mir1a-2 host gene |
1221 |
0.25 |
chr9_69454872_69455904 | 3.45 |
Anxa2 |
annexin A2 |
1322 |
0.26 |
chr2_160622022_160622480 | 3.44 |
Gm23968 |
predicted gene, 23968 |
2217 |
0.24 |
chr2_114054589_114054921 | 3.43 |
C130080G10Rik |
RIKEN cDNA C130080G10 gene |
359 |
0.79 |
chr8_45629766_45630749 | 3.43 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
2056 |
0.32 |
chr2_80036063_80037075 | 3.42 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
2460 |
0.41 |
chr11_65365639_65365874 | 3.38 |
Gm12295 |
predicted gene 12295 |
42 |
0.99 |
chr18_4636274_4636995 | 3.36 |
Jcad |
junctional cadherin 5 associated |
1756 |
0.43 |
chr10_30841590_30841797 | 3.36 |
Hey2 |
hairy/enhancer-of-split related with YRPW motif 2 |
322 |
0.88 |
chr16_91917498_91918270 | 3.34 |
Gm25245 |
predicted gene, 25245 |
3531 |
0.14 |
chr6_127034730_127034972 | 3.33 |
Fgf6 |
fibroblast growth factor 6 |
19265 |
0.11 |
chr5_76859170_76859425 | 3.33 |
C530008M17Rik |
RIKEN cDNA C530008M17 gene |
455 |
0.81 |
chr13_16018459_16019177 | 3.30 |
Inhba |
inhibin beta-A |
4343 |
0.15 |
chr6_48839906_48841160 | 3.28 |
Tmem176b |
transmembrane protein 176B |
62 |
0.82 |
chr10_63460882_63461066 | 3.26 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
3464 |
0.23 |
chr8_109105684_109105963 | 3.25 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
30578 |
0.23 |
chr1_93802092_93802332 | 3.25 |
Dtymk |
deoxythymidylate kinase |
278 |
0.82 |
chr10_81426043_81427197 | 3.24 |
Nfic |
nuclear factor I/C |
494 |
0.54 |
chr8_70791691_70792390 | 3.23 |
Mast3 |
microtubule associated serine/threonine kinase 3 |
361 |
0.67 |
chr7_44857043_44857287 | 3.19 |
Pnkp |
polynucleotide kinase 3'- phosphatase |
2 |
0.93 |
chr7_92181398_92181774 | 3.19 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
805 |
0.71 |
chr5_98029380_98029719 | 3.15 |
Antxr2 |
anthrax toxin receptor 2 |
1413 |
0.32 |
chr18_60963604_60964955 | 3.14 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
679 |
0.59 |
chr11_95842786_95844010 | 3.13 |
Gngt2 |
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
166 |
0.86 |
chr7_135714528_135714949 | 3.13 |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
1623 |
0.33 |
chrX_157699656_157699990 | 3.12 |
Smpx |
small muscle protein, X-linked |
563 |
0.7 |
chr15_77202946_77203567 | 3.12 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
180 |
0.94 |
chr2_76805230_76805433 | 3.12 |
Ttn |
titin |
21211 |
0.22 |
chr17_81740148_81740428 | 3.11 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
1911 |
0.45 |
chr8_41039372_41040105 | 3.11 |
Gm16192 |
predicted gene 16192 |
18 |
0.65 |
chr8_24437736_24437951 | 3.09 |
Tcim |
transcriptional and immune response regulator |
1141 |
0.42 |
chr2_85136489_85137970 | 3.08 |
Aplnr |
apelin receptor |
163 |
0.93 |
chr11_90389095_90389310 | 3.06 |
Hlf |
hepatic leukemia factor |
388 |
0.91 |
chr8_57319308_57320679 | 3.05 |
Hand2os1 |
Hand2, opposite strand 1 |
63 |
0.94 |
chr7_45153720_45154229 | 3.02 |
Pih1d1 |
PIH1 domain containing 1 |
329 |
0.46 |
chr11_69258061_69258264 | 3.01 |
Gm23194 |
predicted gene, 23194 |
17563 |
0.09 |
chr5_108749895_108750174 | 2.99 |
Rnf212 |
ring finger protein 212 |
586 |
0.63 |
chr10_14017752_14018957 | 2.97 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
51330 |
0.13 |
chr2_80037645_80038971 | 2.96 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
721 |
0.79 |
chr19_25343674_25344266 | 2.96 |
Gm34432 |
predicted gene, 34432 |
3233 |
0.31 |
chr2_127728515_127728972 | 2.94 |
Mall |
mal, T cell differentiation protein-like |
1189 |
0.38 |
chr10_128526284_128526761 | 2.92 |
Esyt1 |
extended synaptotagmin-like protein 1 |
651 |
0.37 |
chrX_106839224_106840351 | 2.91 |
Rtl3 |
retrotransposon Gag like 3 |
857 |
0.6 |
chr14_31208319_31209141 | 2.90 |
Tnnc1 |
troponin C, cardiac/slow skeletal |
398 |
0.71 |
chr3_19644566_19645227 | 2.89 |
Trim55 |
tripartite motif-containing 55 |
388 |
0.83 |
chr3_79887847_79889192 | 2.89 |
Gm36569 |
predicted gene, 36569 |
1713 |
0.31 |
chr8_85363277_85363745 | 2.85 |
Mylk3 |
myosin light chain kinase 3 |
1813 |
0.26 |
chr16_38362450_38363226 | 2.85 |
Popdc2 |
popeye domain containing 2 |
593 |
0.63 |
chr11_90388563_90388804 | 2.83 |
Hlf |
hepatic leukemia factor |
476 |
0.87 |
chr14_31166307_31168596 | 2.83 |
Stab1 |
stabilin 1 |
1144 |
0.34 |
chr15_32243989_32244632 | 2.82 |
Snhg18 |
small nucleolar RNA host gene 18 |
352 |
0.58 |
chr14_120277268_120277691 | 2.81 |
Mbnl2 |
muscleblind like splicing factor 2 |
1749 |
0.46 |
chr13_110400077_110400840 | 2.81 |
Plk2 |
polo like kinase 2 |
2661 |
0.34 |
chr13_83527676_83528436 | 2.80 |
Mef2c |
myocyte enhancer factor 2C |
2082 |
0.45 |
chr3_102088246_102088855 | 2.80 |
Casq2 |
calsequestrin 2 |
1911 |
0.26 |
chr5_146833178_146834120 | 2.80 |
Rpl21 |
ribosomal protein L21 |
447 |
0.63 |
chr17_56325228_56325688 | 2.77 |
Kdm4b |
lysine (K)-specific demethylase 4B |
604 |
0.6 |
chr6_149141275_149141845 | 2.77 |
Etfbkmt |
electron transfer flavoprotein beta subunit lysine methyltransferase |
4 |
0.97 |
chr10_59616906_59617057 | 2.75 |
Mcu |
mitochondrial calcium uniporter |
289 |
0.82 |
chr1_13293396_13293901 | 2.74 |
Gm38223 |
predicted gene, 38223 |
3142 |
0.16 |
chr11_40691216_40691367 | 2.74 |
Mat2b |
methionine adenosyltransferase II, beta |
1330 |
0.4 |
chr3_72738646_72738797 | 2.73 |
Gm22451 |
predicted gene, 22451 |
740 |
0.79 |
chr16_14706735_14707615 | 2.73 |
Snai2 |
snail family zinc finger 2 |
1323 |
0.53 |
chr17_25077528_25081106 | 2.73 |
Tmem204 |
transmembrane protein 204 |
1093 |
0.35 |
chr13_113224004_113224583 | 2.72 |
Gzmk |
granzyme K |
1615 |
0.34 |
chr11_34047188_34048526 | 2.72 |
Lcp2 |
lymphocyte cytosolic protein 2 |
689 |
0.72 |
chr1_136915480_136915909 | 2.70 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
24889 |
0.19 |
chr13_110399729_110399880 | 2.68 |
Plk2 |
polo like kinase 2 |
2007 |
0.4 |
chr9_69453423_69454717 | 2.68 |
Anxa2 |
annexin A2 |
4 |
0.96 |
chr7_113737976_113738212 | 2.66 |
Gm29507 |
predicted gene 29507 |
8440 |
0.19 |
chr5_108691915_108692880 | 2.66 |
Fgfrl1 |
fibroblast growth factor receptor-like 1 |
15 |
0.96 |
chr12_111813268_111813845 | 2.65 |
Xrcc3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
285 |
0.7 |
chr15_41163834_41164117 | 2.65 |
4930555K19Rik |
RIKEN cDNA 4930555K19 gene |
9512 |
0.28 |
chr15_81584793_81585093 | 2.64 |
1110025M09Rik |
RIKEN cDNA 1110025M09 gene |
85 |
0.81 |
chr2_65860253_65860846 | 2.64 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
48 |
0.52 |
chr2_34373019_34373518 | 2.64 |
Pbx3 |
pre B cell leukemia homeobox 3 |
126 |
0.96 |
chr2_69670826_69672050 | 2.63 |
Klhl41 |
kelch-like 41 |
1318 |
0.37 |
chr2_59881590_59881865 | 2.62 |
Wdsub1 |
WD repeat, SAM and U-box domain containing 1 |
820 |
0.65 |
chr9_101196762_101197254 | 2.62 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
1843 |
0.24 |
chr6_37438936_37439468 | 2.62 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
2944 |
0.36 |
chr17_34602634_34603562 | 2.62 |
Rnf5 |
ring finger protein 5 |
278 |
0.66 |
chr2_114049476_114049927 | 2.62 |
Actc1 |
actin, alpha, cardiac muscle 1 |
3186 |
0.2 |
chr2_4564405_4564703 | 2.61 |
Frmd4a |
FERM domain containing 4A |
1622 |
0.4 |
chr11_102881246_102881672 | 2.61 |
Ccdc103 |
coiled-coil domain containing 103 |
214 |
0.7 |
chr1_138244489_138245049 | 2.60 |
1700113B19Rik |
RIKEN cDNA 1700113B19 gene |
16873 |
0.15 |
chr8_4325268_4325664 | 2.59 |
Elavl1 |
ELAV (embryonic lethal, abnormal vision)-like 1 (Hu antigen R) |
53 |
0.72 |
chr1_140841258_140841409 | 2.58 |
Gm37371 |
predicted gene, 37371 |
18006 |
0.29 |
chr4_151997129_151997280 | 2.58 |
Phf13 |
PHD finger protein 13 |
946 |
0.38 |
chr2_122377146_122377402 | 2.57 |
Shf |
Src homology 2 domain containing F |
8112 |
0.13 |
chr12_103336858_103338251 | 2.57 |
Gm15523 |
predicted gene 15523 |
648 |
0.43 |
chr4_129584627_129585366 | 2.56 |
Fam167b |
family with sequence similarity 167, member B |
6447 |
0.08 |
chr15_36715797_36716780 | 2.56 |
Gm49263 |
predicted gene, 49263 |
7359 |
0.15 |
chr12_44044424_44045055 | 2.56 |
Gm47056 |
predicted gene, 47056 |
77017 |
0.09 |
chr9_18291650_18292028 | 2.55 |
Chordc1 |
cysteine and histidine-rich domain (CHORD)-containing, zinc-binding protein 1 |
286 |
0.87 |
chr14_56575078_56575869 | 2.54 |
Cenpj |
centromere protein J |
48 |
0.63 |
chr1_87620304_87621692 | 2.54 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
371 |
0.85 |
chr15_68259250_68259461 | 2.52 |
Zfat |
zinc finger and AT hook domain containing |
499 |
0.8 |
chr6_112275706_112275857 | 2.52 |
Lmcd1 |
LIM and cysteine-rich domains 1 |
2023 |
0.27 |
chr18_88244787_88244938 | 2.51 |
Gm50391 |
predicted gene, 50391 |
148312 |
0.04 |
chr19_12010125_12011032 | 2.51 |
Olfr1421-ps1 |
olfactory receptor 1421, pseudogene 1 |
9597 |
0.08 |
chr16_4788242_4788682 | 2.50 |
Cdip1 |
cell death inducing Trp53 target 1 |
1468 |
0.3 |
chr12_54201328_54201719 | 2.49 |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
2337 |
0.27 |
chr19_46623097_46624579 | 2.48 |
Wbp1l |
WW domain binding protein 1 like |
437 |
0.77 |
chr12_95698451_95698602 | 2.47 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
3169 |
0.23 |
chr6_141250969_141251472 | 2.46 |
Gm28523 |
predicted gene 28523 |
1211 |
0.38 |
chr9_107298004_107299417 | 2.44 |
Cish |
cytokine inducible SH2-containing protein |
445 |
0.63 |
chr19_45658068_45658227 | 2.44 |
Fbxw4 |
F-box and WD-40 domain protein 4 |
2165 |
0.32 |
chr15_78571734_78572724 | 2.44 |
Rac2 |
Rac family small GTPase 2 |
552 |
0.62 |
chrX_29563834_29564241 | 2.44 |
Gm15432 |
predicted gene 15432 |
171 |
0.97 |
chr10_26564459_26564925 | 2.44 |
Gm48864 |
predicted gene, 48864 |
46055 |
0.14 |
chr11_69324057_69324561 | 2.43 |
Trappc1 |
trafficking protein particle complex 1 |
129 |
0.8 |
chr2_118113734_118115108 | 2.43 |
Thbs1 |
thrombospondin 1 |
2545 |
0.2 |
chr11_94500251_94500402 | 2.43 |
Epn3 |
epsin 3 |
352 |
0.8 |
chr15_53310669_53311940 | 2.43 |
Ext1 |
exostosin glycosyltransferase 1 |
34355 |
0.22 |
chr19_57359163_57359516 | 2.42 |
Fam160b1 |
family with sequence similarity 160, member B1 |
1341 |
0.3 |
chr8_45975042_45975429 | 2.42 |
1700029J07Rik |
RIKEN cDNA 1700029J07 gene |
17 |
0.8 |
chrX_157700177_157700800 | 2.41 |
Smpx |
small muscle protein, X-linked |
1228 |
0.39 |
chr4_109147263_109147688 | 2.41 |
Osbpl9 |
oxysterol binding protein-like 9 |
9135 |
0.22 |
chr3_8923882_8924255 | 2.41 |
Mrps28 |
mitochondrial ribosomal protein S28 |
150 |
0.96 |
chr18_69399329_69399820 | 2.41 |
Tcf4 |
transcription factor 4 |
16323 |
0.27 |
chr1_33997511_33997695 | 2.40 |
Dst |
dystonin |
8277 |
0.15 |
chr10_18845717_18847414 | 2.39 |
Perp |
PERP, TP53 apoptosis effector |
1545 |
0.37 |
chr1_180812210_180812890 | 2.38 |
H3f3a |
H3.3 histone A |
984 |
0.32 |
chr10_53336408_53337060 | 2.37 |
Pln |
phospholamban |
933 |
0.46 |
chr12_33313990_33315181 | 2.36 |
Atxn7l1 |
ataxin 7-like 1 |
185 |
0.95 |
chr2_143917101_143917550 | 2.34 |
Dstn |
destrin |
2005 |
0.27 |
chr6_3399116_3399544 | 2.33 |
Samd9l |
sterile alpha motif domain containing 9-like |
242 |
0.92 |
chr2_155518061_155518765 | 2.33 |
Ggt7 |
gamma-glutamyltransferase 7 |
176 |
0.64 |
chr3_116968200_116969270 | 2.33 |
Palmd |
palmdelphin |
8 |
0.89 |
chr5_114378285_114378463 | 2.32 |
Kctd10 |
potassium channel tetramerisation domain containing 10 |
2109 |
0.21 |
chr18_39484877_39485553 | 2.32 |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
2017 |
0.42 |
chr9_87728785_87728936 | 2.32 |
D030062O11Rik |
RIKEN cDNA D030062O11 gene |
425 |
0.78 |
chr2_72978014_72978165 | 2.32 |
Sp3 |
trans-acting transcription factor 3 |
1197 |
0.31 |
chr8_77518593_77518744 | 2.31 |
0610038B21Rik |
RIKEN cDNA 0610038B21 gene |
553 |
0.51 |
chr7_109879032_109879458 | 2.31 |
Scube2 |
signal peptide, CUB domain, EGF-like 2 |
13566 |
0.15 |
chr18_37997868_37999258 | 2.31 |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
170 |
0.9 |
chr10_26772177_26773494 | 2.31 |
Arhgap18 |
Rho GTPase activating protein 18 |
288 |
0.91 |
chr16_14159665_14159866 | 2.30 |
Mir484 |
microRNA 484 |
139 |
0.82 |
chr7_101896002_101896260 | 2.29 |
Anapc15 |
anaphase promoting complex C subunit 15 |
101 |
0.92 |
chr3_60529662_60530216 | 2.28 |
Mbnl1 |
muscleblind like splicing factor 1 |
308 |
0.91 |
chr18_69084174_69085263 | 2.28 |
Mir145b |
microRNA 145b |
62445 |
0.11 |
chr3_30602009_30602258 | 2.27 |
Mynn |
myoneurin |
68 |
0.95 |
chr18_13973933_13974513 | 2.27 |
Zfp521 |
zinc finger protein 521 |
1436 |
0.55 |
chr15_81522316_81522682 | 2.26 |
Gm5218 |
predicted gene 5218 |
22954 |
0.11 |
chr5_65765287_65765445 | 2.25 |
N4bp2os |
NEDD4 binding protein 2, opposite strand |
987 |
0.33 |
chr1_84619208_84619870 | 2.25 |
Dner |
delta/notch-like EGF repeat containing |
4302 |
0.26 |
chr18_23803452_23803822 | 2.25 |
Mapre2 |
microtubule-associated protein, RP/EB family, member 2 |
347 |
0.86 |
chr9_32343665_32344898 | 2.25 |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
1 |
0.97 |
chr2_148404054_148404505 | 2.25 |
Thbd |
thrombomodulin |
3909 |
0.19 |
chr19_8991585_8992257 | 2.25 |
Ahnak |
AHNAK nucleoprotein (desmoyokin) |
2626 |
0.14 |
chr16_5204039_5204205 | 2.24 |
Nagpa |
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase |
110 |
0.93 |
chr13_63250580_63250802 | 2.24 |
Gm47603 |
predicted gene, 47603 |
4873 |
0.1 |
chr4_6365315_6365633 | 2.23 |
Sdcbp |
syndecan binding protein |
176 |
0.94 |
chr2_59438620_59439113 | 2.23 |
Gm13549 |
predicted gene 13549 |
39085 |
0.13 |
chr1_52233456_52233834 | 2.23 |
Gls |
glutaminase |
413 |
0.86 |
chr4_88720999_88721150 | 2.22 |
Gm26566 |
predicted gene, 26566 |
731 |
0.28 |
chr14_120275740_120276154 | 2.22 |
Mbnl2 |
muscleblind like splicing factor 2 |
217 |
0.96 |
chr2_7080065_7080255 | 2.22 |
Celf2 |
CUGBP, Elav-like family member 2 |
1047 |
0.66 |
chr15_98606352_98606619 | 2.22 |
Adcy6 |
adenylate cyclase 6 |
1148 |
0.29 |
chr14_77141513_77141727 | 2.21 |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
15143 |
0.21 |
chr14_61680601_61680752 | 2.21 |
Gm37472 |
predicted gene, 37472 |
818 |
0.4 |
chr10_71250590_71250827 | 2.21 |
Ube2d1 |
ubiquitin-conjugating enzyme E2D 1 |
6180 |
0.14 |
chr10_63203190_63203876 | 2.20 |
Mypn |
myopalladin |
419 |
0.79 |
chr15_75921076_75921501 | 2.20 |
Pycrl |
pyrroline-5-carboxylate reductase-like |
272 |
0.79 |
chr5_21374530_21374785 | 2.20 |
Fgl2 |
fibrinogen-like protein 2 |
2015 |
0.33 |
chr3_57667227_57667681 | 2.20 |
BB187690 |
expressed sequence BB187690 |
11875 |
0.11 |
chr8_80493129_80493898 | 2.20 |
Gypa |
glycophorin A |
268 |
0.93 |
chr10_108445980_108446302 | 2.20 |
Gm36283 |
predicted gene, 36283 |
461 |
0.82 |
chr3_116806554_116807301 | 2.19 |
Agl |
amylo-1,6-glucosidase, 4-alpha-glucanotransferase |
490 |
0.71 |
chr16_59599420_59599980 | 2.19 |
Crybg3 |
beta-gamma crystallin domain containing 3 |
1279 |
0.47 |
chr19_8774094_8774416 | 2.19 |
Tmem179b |
transmembrane protein 179B |
190 |
0.76 |
chr10_113916873_113917024 | 2.19 |
Gm38333 |
predicted gene, 38333 |
79699 |
0.11 |
chr5_98028905_98029056 | 2.19 |
Antxr2 |
anthrax toxin receptor 2 |
1982 |
0.25 |
chr3_128990459_128991248 | 2.19 |
Gm9387 |
predicted pseudogene 9387 |
35755 |
0.19 |
chr11_75467582_75468787 | 2.19 |
Tlcd2 |
TLC domain containing 2 |
105 |
0.91 |
chr18_65392658_65392927 | 2.17 |
Alpk2 |
alpha-kinase 2 |
1102 |
0.35 |
chr7_112956295_112957421 | 2.17 |
Rassf10 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 10 |
2896 |
0.26 |
chr3_68691095_68691751 | 2.17 |
Il12a |
interleukin 12a |
1 |
0.98 |
chr13_34002914_34003183 | 2.17 |
Ripk1 |
receptor (TNFRSF)-interacting serine-threonine kinase 1 |
174 |
0.59 |
chr2_143916831_143917027 | 2.17 |
Dstn |
destrin |
1609 |
0.32 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.8 | 3.5 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
1.7 | 5.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.7 | 5.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.5 | 4.6 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.2 | 2.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.2 | 4.7 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
1.2 | 3.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
1.2 | 4.7 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.2 | 3.5 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.2 | 3.5 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
1.1 | 6.9 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.1 | 3.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.1 | 3.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.1 | 3.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.0 | 5.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.0 | 3.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.0 | 3.9 | GO:0008228 | opsonization(GO:0008228) |
1.0 | 1.0 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.9 | 3.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.9 | 4.5 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.9 | 2.7 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.9 | 2.7 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.9 | 2.6 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.9 | 2.6 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.9 | 2.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.9 | 1.7 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.9 | 0.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.8 | 4.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.8 | 3.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.8 | 2.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.8 | 3.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.8 | 2.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.8 | 4.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.8 | 0.8 | GO:0003175 | tricuspid valve development(GO:0003175) |
0.8 | 3.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.8 | 4.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.8 | 2.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.8 | 2.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.8 | 3.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.8 | 2.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.8 | 3.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.7 | 3.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.7 | 2.2 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.7 | 1.5 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.7 | 4.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.7 | 2.2 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.7 | 0.7 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.7 | 2.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 2.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.7 | 2.1 | GO:0042520 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.7 | 2.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.7 | 4.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.7 | 3.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.7 | 4.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 0.7 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.7 | 1.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.6 | 1.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.6 | 3.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.6 | 0.6 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.6 | 5.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.6 | 3.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.6 | 1.3 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.6 | 1.9 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.6 | 3.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.6 | 4.9 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.6 | 2.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.6 | 3.6 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.6 | 2.4 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.6 | 0.6 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.6 | 4.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.6 | 1.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 5.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.6 | 1.8 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.6 | 1.8 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.6 | 2.4 | GO:0002001 | renin secretion into blood stream(GO:0002001) |
0.6 | 1.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.6 | 2.4 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.6 | 1.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.6 | 0.6 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.6 | 1.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.6 | 2.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.6 | 1.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.6 | 1.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.6 | 1.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.6 | 1.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.6 | 2.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.6 | 1.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.6 | 3.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.6 | 1.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.6 | 2.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.6 | 1.7 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.5 | 2.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.5 | 2.7 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.5 | 0.5 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.5 | 2.1 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.5 | 1.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.5 | 1.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.5 | 1.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.5 | 1.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 5.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 2.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.5 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.5 | 2.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 0.5 | GO:0016093 | polyprenol metabolic process(GO:0016093) polyprenol catabolic process(GO:0016095) |
0.5 | 2.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.5 | 1.0 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.5 | 1.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.5 | 1.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.5 | 1.5 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.5 | 5.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 2.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.5 | 1.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.5 | 2.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.5 | 2.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.5 | 1.5 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 1.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.5 | 1.0 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.5 | 1.5 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.5 | 1.5 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.5 | 2.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.5 | 1.5 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.5 | 1.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.5 | 1.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.5 | 1.9 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.5 | 1.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.5 | 1.4 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.5 | 1.0 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 2.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.5 | 1.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 0.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.5 | 2.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.5 | 5.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.5 | 1.9 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.5 | 1.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 1.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 3.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 1.9 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.5 | 1.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 2.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.5 | 1.4 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.5 | 1.8 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.5 | 0.9 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.5 | 1.8 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 1.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.5 | 0.9 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.5 | 4.1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.5 | 1.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 1.8 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.5 | 2.3 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 1.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 2.7 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.4 | 1.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.4 | 2.7 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 | 1.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.4 | 1.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 1.8 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 0.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.4 | 2.2 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.4 | 2.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 2.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 0.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.4 | 5.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.4 | 1.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.4 | 1.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 1.3 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 1.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.4 | 2.6 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.4 | 1.3 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.4 | 1.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.4 | 2.2 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.4 | 1.3 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.4 | 3.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.4 | 1.7 | GO:0048143 | astrocyte activation(GO:0048143) |
0.4 | 1.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 1.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.4 | 1.7 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.4 | 1.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.4 | 1.7 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.4 | 1.3 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.4 | 1.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 0.8 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.4 | 3.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 1.7 | GO:0050904 | diapedesis(GO:0050904) |
0.4 | 1.7 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 0.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.4 | 2.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 2.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 2.5 | GO:0009650 | UV protection(GO:0009650) |
0.4 | 2.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.4 | 2.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.4 | 6.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 1.6 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.4 | 1.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 3.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.4 | 0.4 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.4 | 1.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 1.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 0.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 1.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.4 | 2.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 0.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.4 | 2.8 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.4 | 13.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.4 | 1.2 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.4 | 1.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 3.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.4 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 1.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 1.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.4 | 1.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.4 | 0.4 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.4 | 1.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.4 | 1.5 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.4 | 0.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.4 | 1.5 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.4 | 1.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 1.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.4 | 1.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.4 | 1.9 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.4 | 1.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.4 | 1.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.4 | 0.7 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.4 | 1.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 0.7 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.4 | 0.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.4 | 1.5 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 0.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 1.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 0.7 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.4 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 1.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 0.4 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.4 | 4.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 1.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 1.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.4 | 1.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 0.4 | GO:0002339 | B cell selection(GO:0002339) |
0.4 | 0.7 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.4 | 1.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 0.4 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.4 | 0.4 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 0.4 | GO:0007512 | adult heart development(GO:0007512) |
0.4 | 1.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 0.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 2.8 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.3 | 0.7 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.3 | 1.0 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.3 | 0.7 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 2.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 1.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 3.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.3 | 2.1 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.3 | 2.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 0.7 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.3 | 1.0 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 1.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 2.7 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 0.7 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.3 | 1.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 1.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 0.7 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 2.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 2.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 1.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 1.7 | GO:0042737 | drug catabolic process(GO:0042737) |
0.3 | 1.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 1.7 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.3 | 1.0 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 1.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.3 | 2.0 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.3 | 1.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 0.7 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 0.7 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 0.7 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 3.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.3 | 3.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 1.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 1.3 | GO:0097531 | mast cell migration(GO:0097531) |
0.3 | 2.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 1.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 1.3 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 2.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.3 | 1.6 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 1.3 | GO:0035482 | gastric motility(GO:0035482) |
0.3 | 0.7 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.3 | 2.0 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 1.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 4.6 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 2.3 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 2.3 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 1.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 0.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.3 | 1.3 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.3 | 2.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 1.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 1.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 2.9 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.3 | 2.9 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.3 | 1.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.3 | 1.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.3 | 0.3 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.3 | 0.9 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.3 | 0.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 0.6 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 0.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 1.3 | GO:0042701 | progesterone secretion(GO:0042701) |
0.3 | 5.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 0.9 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.3 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 0.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 0.9 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.3 | GO:0100012 | regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
0.3 | 0.6 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 0.3 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.3 | 2.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.3 | 0.9 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.3 | 2.8 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 0.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 0.6 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.3 | 0.6 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.3 | 0.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 2.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 0.3 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.3 | 1.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 1.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 1.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.3 | 1.2 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.3 | 1.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.3 | 3.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 1.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 2.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 8.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 0.9 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 1.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 0.6 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 2.3 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.3 | 1.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 1.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.3 | 0.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 1.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 0.9 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 1.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 2.0 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.3 | 0.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.3 | 1.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.3 | 1.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.3 | 1.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 4.0 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.3 | 0.6 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.3 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.3 | 1.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.3 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.3 | 0.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 2.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 0.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 1.4 | GO:0015791 | polyol transport(GO:0015791) |
0.3 | 0.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.3 | 1.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.9 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.3 | 1.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 3.3 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.3 | 1.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.8 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 0.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.3 | 1.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 1.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 0.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 0.8 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.3 | 0.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.5 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.3 | 1.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 0.5 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.3 | 0.5 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.3 | 2.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 2.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 0.3 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.3 | 1.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 1.8 | GO:0033572 | transferrin transport(GO:0033572) |
0.3 | 1.3 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 1.3 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 0.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.3 | 0.8 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 0.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 0.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 2.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 0.3 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.3 | 1.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 0.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.3 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 0.3 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 2.8 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.3 | 0.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 1.8 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.3 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.3 | 1.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 2.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 0.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 4.6 | GO:0033363 | secretory granule organization(GO:0033363) |
0.3 | 1.3 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.3 | 0.8 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.3 | 1.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 0.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 4.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 0.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 2.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.3 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.3 | 0.8 | GO:0007418 | ventral midline development(GO:0007418) |
0.3 | 1.5 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.3 | 0.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 2.3 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.3 | 1.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 1.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 1.5 | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) |
0.2 | 0.7 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 0.7 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.2 | 1.5 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 0.5 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 0.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.2 | 6.0 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.2 | 1.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 1.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.7 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 5.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 0.7 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.2 | 1.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 1.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 0.7 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.5 | GO:2001259 | positive regulation of cation channel activity(GO:2001259) |
0.2 | 5.3 | GO:0042168 | heme metabolic process(GO:0042168) |
0.2 | 2.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 4.6 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.2 | 1.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 0.5 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.2 | 1.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 3.6 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.2 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.2 | 2.6 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 0.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 1.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.2 | 1.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 1.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.7 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.2 | 0.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 2.4 | GO:0032392 | DNA geometric change(GO:0032392) |
0.2 | 0.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.7 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.2 | 0.7 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.5 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 1.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.2 | 2.4 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.2 | 0.7 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 0.7 | GO:0007567 | parturition(GO:0007567) |
0.2 | 3.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 0.5 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 1.6 | GO:0046479 | ganglioside catabolic process(GO:0006689) glycosphingolipid catabolic process(GO:0046479) |
0.2 | 0.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.5 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.7 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 3.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 2.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.7 | GO:0010226 | response to lithium ion(GO:0010226) |
0.2 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 1.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 4.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 0.2 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 0.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.2 | 2.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.9 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 0.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 1.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 7.6 | GO:0043039 | amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.2 | 0.7 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 0.2 | GO:0042977 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) |
0.2 | 0.9 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 1.3 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.2 | 2.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.2 | 0.9 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.9 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 0.4 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.2 | 1.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 0.4 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.2 | 0.7 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.2 | 1.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 0.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 2.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.7 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 2.4 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.2 | 1.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.7 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 0.9 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.2 | 1.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.9 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 1.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 1.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 0.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.2 | 0.9 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 1.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 3.0 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.2 | 0.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 1.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.6 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 0.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.4 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 0.6 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.2 | 0.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.4 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 1.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.8 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 1.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 2.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 1.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.2 | 1.0 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.4 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.2 | 2.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.2 | 1.0 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 0.6 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.2 | 0.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.2 | 0.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.6 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 1.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.4 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.6 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 3.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 2.5 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 2.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 1.6 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.2 | 0.4 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.2 | 0.6 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.2 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.6 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.2 | 1.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 5.6 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 0.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 1.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 2.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 2.2 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.2 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 1.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 4.3 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 0.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 0.2 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.2 | 2.3 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.2 | 0.8 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 2.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 1.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 2.3 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.2 | 0.8 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 2.5 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 0.8 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 2.7 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.2 | 2.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 1.3 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.2 | 0.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.6 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 0.6 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.2 | 1.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.2 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.2 | 0.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 2.4 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 0.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.7 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 2.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 4.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 1.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 1.5 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.2 | 1.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.2 | 2.0 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.5 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 3.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 1.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 7.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 0.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 0.5 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.2 | 1.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 2.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 1.8 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.2 | 0.9 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 4.0 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.2 | 0.5 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.2 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 2.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 1.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 0.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.5 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.2 | 0.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.7 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 0.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 1.2 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.2 | 0.2 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
0.2 | 4.6 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 4.2 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 1.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 1.6 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 0.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 1.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.2 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.2 | 0.3 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.2 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 0.2 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 1.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 2.1 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.2 | 1.4 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 0.9 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.2 | 0.7 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.2 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 0.9 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.9 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.2 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.7 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 7.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.3 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 3.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 1.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 1.0 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 1.5 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.2 | 0.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.3 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 1.0 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.2 | GO:0034145 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.2 | 0.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 1.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.2 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.2 | 1.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 1.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 1.3 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.2 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.2 | 0.5 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.2 | 1.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.3 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.2 | 0.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.2 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.2 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.2 | GO:0071025 | RNA surveillance(GO:0071025) |
0.2 | 0.2 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 0.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.2 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.2 | 1.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 1.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 0.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.2 | 0.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.5 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 1.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.2 | 0.9 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.2 | 0.8 | GO:1901570 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.2 | 3.8 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.2 | 0.5 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.8 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 0.3 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.2 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 1.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.6 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.2 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.2 | 0.6 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 0.8 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.2 | 2.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.2 | 1.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 2.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 2.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 1.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 1.1 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.2 | 1.1 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.2 | 0.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.8 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.4 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.1 | 0.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.7 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.4 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 1.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 4.9 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 1.0 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.1 | 0.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 3.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.4 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 1.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.7 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.1 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.6 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 2.7 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.1 | 0.3 | GO:0097468 | hydrogen peroxide-mediated programmed cell death(GO:0010421) programmed cell death in response to reactive oxygen species(GO:0097468) regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.1 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 1.0 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 1.6 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.1 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.3 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 1.0 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.8 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 4.8 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.3 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 1.0 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.6 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.1 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.1 | 1.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.3 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 1.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 2.6 | GO:0051591 | response to cAMP(GO:0051591) |
0.1 | 4.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.5 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 1.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:0090160 | regulation of natural killer cell degranulation(GO:0043321) Golgi to lysosome transport(GO:0090160) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.3 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 0.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.3 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.1 | 1.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 1.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.4 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 3.4 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.4 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.1 | 0.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.3 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.4 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.3 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 1.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 2.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 1.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 1.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.3 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 2.7 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.0 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 1.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.3 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.4 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.2 | GO:0042998 | regulation of Golgi to plasma membrane protein transport(GO:0042996) positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 1.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 1.0 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 2.8 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.1 | 2.8 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.1 | 0.2 | GO:0098751 | bone cell development(GO:0098751) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 1.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 1.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.5 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.1 | 0.2 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 1.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.7 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.5 | GO:0070252 | actin-mediated cell contraction(GO:0070252) |
0.1 | 0.1 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.1 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 1.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.6 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.4 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.4 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.1 | 1.9 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.9 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 2.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.9 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.6 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.1 | 0.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 4.7 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 0.2 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 1.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 1.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.1 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.3 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 1.1 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.2 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.1 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.1 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.1 | 0.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 1.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.4 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.3 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 0.3 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.1 | 0.1 | GO:1903551 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.2 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.1 | 1.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 2.1 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 2.3 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 3.5 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 0.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.3 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 1.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.6 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.6 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 1.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.5 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.2 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.3 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 0.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 1.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.1 | 0.3 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 2.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.4 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.1 | 0.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.4 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.1 | 1.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.2 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.1 | 0.2 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 0.3 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.7 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 2.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 1.9 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.6 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.1 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.7 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.1 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.1 | 0.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.7 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.1 | 0.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.3 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.1 | 0.7 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.1 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.2 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.3 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.8 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 0.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.3 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.1 | 0.1 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.1 | 0.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 1.9 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.3 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.2 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.3 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.1 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 3.9 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.2 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 3.9 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.7 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.1 | 0.5 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.1 | 0.7 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.1 | 1.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 4.2 | GO:0098792 | xenophagy(GO:0098792) |
0.1 | 0.2 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.8 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 1.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 1.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.1 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 1.2 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.5 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.1 | 0.4 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.1 | 0.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 0.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.1 | 0.2 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.2 | GO:0015677 | copper ion import(GO:0015677) |
0.1 | 0.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 1.3 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 0.2 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
0.1 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.1 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 1.8 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.1 | 1.6 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.5 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
0.1 | 0.2 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
0.1 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.8 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 1.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.6 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.1 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.1 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 2.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.6 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.6 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 3.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 1.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.1 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.1 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 1.2 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.8 | GO:0033865 | coenzyme A metabolic process(GO:0015936) nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.1 | 0.6 | GO:0015992 | proton transport(GO:0015992) |
0.1 | 0.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 0.5 | GO:0070570 | regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 3.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.1 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.1 | 0.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.3 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.1 | 1.8 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 0.3 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.3 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.1 | 1.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.1 | GO:0001774 | microglial cell activation(GO:0001774) |
0.1 | 0.2 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.1 | 0.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.3 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.2 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 1.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 1.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.1 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.1 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 5.1 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 0.4 | GO:1903205 | regulation of hydrogen peroxide-induced cell death(GO:1903205) |
0.1 | 2.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 1.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.3 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.1 | 0.1 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.1 | 1.4 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.2 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 1.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.4 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.4 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.7 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.1 | GO:2001056 | positive regulation of cysteine-type endopeptidase activity(GO:2001056) |
0.1 | 0.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.1 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 1.4 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 0.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 5.6 | GO:0006281 | DNA repair(GO:0006281) |
0.1 | 0.8 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 1.6 | GO:0006941 | striated muscle contraction(GO:0006941) |
0.1 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.2 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.1 | 0.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.5 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.0 | 0.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 1.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.2 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.0 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 1.2 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.0 | 0.4 | GO:0097352 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.0 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.0 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.0 | 0.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.6 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.0 | 0.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 1.2 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 3.0 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.0 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.6 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.6 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.0 | 0.0 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.4 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.1 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.0 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.1 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.0 | 0.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.0 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.9 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.0 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.0 | 0.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 1.7 | GO:0016032 | viral process(GO:0016032) |
0.0 | 0.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.1 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.0 | 0.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 4.4 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.2 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.0 | 1.6 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.4 | GO:0061515 | myeloid cell development(GO:0061515) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.1 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.4 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 1.2 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.6 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.0 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.0 | 0.1 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.0 | 0.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.0 | GO:0032309 | icosanoid secretion(GO:0032309) |
0.0 | 0.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.3 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.0 | GO:0034146 | positive regulation of toll-like receptor signaling pathway(GO:0034123) toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.0 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.2 | GO:0007099 | centriole replication(GO:0007099) |
0.0 | 0.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.0 | GO:0033079 | immature T cell proliferation(GO:0033079) |
0.0 | 0.2 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.0 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.7 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 2.0 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.0 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.0 | 0.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.0 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.0 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.0 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:0007127 | meiosis I(GO:0007127) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.1 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.0 | 0.1 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
0.0 | 0.0 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.0 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.9 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.0 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.0 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.0 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.0 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.0 | 0.0 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.0 | 0.1 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.0 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 1.1 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.0 | 0.3 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.0 | 0.0 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.0 | 0.0 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.0 | 0.0 | GO:0086001 | cardiac muscle cell action potential(GO:0086001) |
0.0 | 0.0 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.0 | 0.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.0 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.0 | GO:0002833 | positive regulation of response to biotic stimulus(GO:0002833) |
0.0 | 0.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.0 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.0 | GO:1902882 | regulation of response to oxidative stress(GO:1902882) |
0.0 | 0.0 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.0 | 0.0 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.0 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.0 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0098581 | detection of external biotic stimulus(GO:0098581) |
0.0 | 0.1 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.1 | GO:0044236 | multicellular organism metabolic process(GO:0044236) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.9 | 4.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.8 | 3.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.8 | 2.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.8 | 3.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.8 | 7.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.8 | 4.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.7 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.7 | 2.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 2.1 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.7 | 2.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.6 | 3.8 | GO:0005818 | aster(GO:0005818) |
0.6 | 7.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.6 | 6.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.6 | 2.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.6 | 1.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 2.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.6 | 1.8 | GO:0030891 | VCB complex(GO:0030891) |
0.6 | 3.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 2.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 2.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.6 | 3.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.5 | 2.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 3.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 2.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.5 | 3.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.5 | 1.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.5 | 2.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.5 | 2.0 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 2.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.5 | 5.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.5 | 3.9 | GO:0005861 | troponin complex(GO:0005861) |
0.5 | 1.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 1.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 1.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 1.9 | GO:0044308 | axonal spine(GO:0044308) |
0.5 | 1.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.5 | 1.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 4.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.5 | 4.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 1.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 1.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 2.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 1.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 2.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 2.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 3.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 1.3 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 2.1 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 1.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 1.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 3.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.4 | 4.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 1.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.4 | 0.8 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.4 | 0.4 | GO:0000243 | commitment complex(GO:0000243) |
0.4 | 1.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 5.2 | GO:0031430 | M band(GO:0031430) |
0.4 | 2.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 2.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.4 | 1.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 1.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 3.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 1.1 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 1.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.4 | 1.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 1.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.4 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 1.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 3.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.0 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 6.2 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 2.1 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 1.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 5.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 4.4 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.3 | 2.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 1.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 1.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 4.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 1.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 1.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 1.3 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 4.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 2.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 0.3 | GO:0031261 | GINS complex(GO:0000811) DNA replication preinitiation complex(GO:0031261) |
0.3 | 0.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 1.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 1.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 3.5 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 1.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 1.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 1.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 4.8 | GO:0043205 | fibril(GO:0043205) |
0.3 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 1.0 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 1.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 0.6 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 0.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.3 | 1.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 0.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 1.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 4.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 0.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 1.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 1.2 | GO:0032021 | NELF complex(GO:0032021) |
0.3 | 4.6 | GO:0043034 | costamere(GO:0043034) |
0.3 | 0.9 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 1.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 0.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 1.8 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 0.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 1.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 21.0 | GO:0030018 | Z disc(GO:0030018) |
0.3 | 1.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 0.9 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.3 | 7.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.3 | 4.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 2.9 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 2.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 5.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 2.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 4.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 12.2 | GO:0030017 | sarcomere(GO:0030017) |
0.3 | 1.1 | GO:0035859 | Seh1-associated complex(GO:0035859) Iml1 complex(GO:1990130) |
0.3 | 3.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.3 | 0.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 0.8 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 1.7 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 0.8 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 2.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 0.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 1.9 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 2.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.4 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 0.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 6.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 1.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 1.6 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 2.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 0.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.3 | 6.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.3 | 2.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 0.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 0.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 1.8 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 2.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 1.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 4.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 1.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 5.9 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 1.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 16.1 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.2 | 2.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 0.5 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 1.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 0.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 1.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.2 | GO:0097386 | glial cell projection(GO:0097386) |
0.2 | 1.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 1.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 3.3 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 1.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 1.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.4 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 1.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 2.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.9 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 8.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 5.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 3.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.4 | GO:0005874 | microtubule(GO:0005874) |
0.2 | 0.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 0.7 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 3.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 0.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 4.7 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.2 | 5.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 1.8 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 2.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 1.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 5.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 10.6 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 0.9 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 9.0 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 4.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 6.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 11.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 1.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 1.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 2.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 1.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.8 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.2 | 0.8 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 0.6 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.2 | GO:0034399 | nuclear periphery(GO:0034399) |
0.2 | 1.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 0.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.2 | 1.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 2.6 | GO:0002102 | podosome(GO:0002102) |
0.2 | 7.2 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 1.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 0.6 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 0.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 1.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.2 | 1.4 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 1.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 2.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 2.7 | GO:0030016 | myofibril(GO:0030016) |
0.2 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 3.1 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 1.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 2.5 | GO:1990752 | microtubule end(GO:1990752) |
0.2 | 0.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 2.2 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 1.8 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 2.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.7 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 2.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 10.9 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 2.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 0.7 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 1.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.0 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 2.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 0.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 0.7 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 2.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 7.4 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 2.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 25.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 1.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 7.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 1.0 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 3.9 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 12.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 1.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 3.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 6.8 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 0.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 2.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.8 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 1.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 2.3 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 2.8 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 1.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 6.5 | GO:0030496 | midbody(GO:0030496) |
0.1 | 1.2 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 3.2 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 4.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 1.0 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.9 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 4.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.4 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 5.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.7 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 3.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 5.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 1.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 4.2 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.8 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.1 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 16.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 4.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 6.6 | GO:0005814 | centriole(GO:0005814) |
0.1 | 1.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 2.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.7 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 1.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.0 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.6 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.6 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 6.5 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 1.7 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.6 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.2 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 5.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 115.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 1.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.4 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 4.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 14.9 | GO:0005924 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) |
0.1 | 11.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 1.6 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 1.7 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 1.6 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.1 | 0.4 | GO:0098687 | chromosomal region(GO:0098687) |
0.1 | 6.0 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 7.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 1.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 2.3 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.1 | 6.2 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 1.2 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.3 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 9.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 1.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.1 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 0.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 3.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 9.6 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.1 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.1 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.4 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 2.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 6.8 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 3.6 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 3.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 73.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.6 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 1.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.6 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 1.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.4 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 5.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 3.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:1903561 | extracellular vesicle(GO:1903561) |
0.0 | 0.2 | GO:0031982 | vesicle(GO:0031982) |
0.0 | 0.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.4 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 0.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.0 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.0 | GO:0036452 | ESCRT complex(GO:0036452) |
0.0 | 78.2 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 1.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.0 | GO:0005819 | spindle(GO:0005819) |
0.0 | 1.2 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.0 | 0.1 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.0 | GO:0097470 | ribbon synapse(GO:0097470) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.5 | 6.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.3 | 3.8 | GO:0035939 | microsatellite binding(GO:0035939) |
1.2 | 3.5 | GO:0004359 | glutaminase activity(GO:0004359) |
1.2 | 3.5 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.2 | 3.5 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.1 | 2.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
1.1 | 3.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.0 | 4.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.0 | 3.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.0 | 4.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.0 | 2.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.0 | 3.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.9 | 2.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.9 | 0.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.8 | 3.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.8 | 1.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.8 | 2.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.8 | 3.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.8 | 1.6 | GO:0043398 | HLH domain binding(GO:0043398) |
0.8 | 3.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.7 | 2.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.7 | 0.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.7 | 3.5 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 4.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.7 | 2.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.7 | 2.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.7 | 2.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.7 | 2.7 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.7 | 2.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 2.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.7 | 4.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.7 | 2.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 1.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.6 | 0.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.6 | 2.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.6 | 1.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.6 | 1.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.6 | 2.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.6 | 4.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.6 | 4.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.6 | 2.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.6 | 2.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.6 | 1.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.6 | 4.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.6 | 2.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.6 | 12.2 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.6 | 1.7 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.6 | 5.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.5 | 1.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 1.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 12.4 | GO:0042805 | actinin binding(GO:0042805) |
0.5 | 3.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 2.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 1.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 1.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.5 | 2.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 3.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.5 | 2.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.5 | 1.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.5 | 1.5 | GO:0035877 | death effector domain binding(GO:0035877) |
0.5 | 4.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.5 | 2.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 1.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 1.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.5 | 1.9 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.5 | 0.9 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.5 | 1.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 2.3 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 2.8 | GO:0015288 | porin activity(GO:0015288) |
0.5 | 1.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.5 | 1.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 2.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 1.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.5 | 1.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 13.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 1.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 0.9 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 1.8 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 6.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.4 | 6.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 1.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 2.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 0.9 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 1.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 6.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.4 | 1.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 2.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 4.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 1.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 2.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 0.9 | GO:0070696 | receptor serine/threonine kinase binding(GO:0033612) transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.4 | 1.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 0.8 | GO:0015928 | fucosidase activity(GO:0015928) |
0.4 | 0.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.4 | 2.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 1.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 5.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 1.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 1.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 1.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 1.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 7.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 1.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 1.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.4 | 2.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 1.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.4 | 2.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 1.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 2.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.4 | 2.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 2.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 1.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 1.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 1.2 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.4 | 1.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 1.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 1.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.4 | 1.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.4 | 1.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.4 | 1.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 0.7 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.4 | 1.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 3.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 1.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 2.1 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 1.4 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.4 | 2.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 1.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 2.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 1.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.3 | 2.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 2.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 1.4 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.3 | 2.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 1.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 1.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 3.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 1.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 1.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 2.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 2.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 2.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 2.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 1.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 1.6 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 0.9 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.3 | 2.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 5.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 1.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 0.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 1.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 0.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 1.2 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 1.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.3 | 1.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.3 | 0.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 0.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 2.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 2.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 0.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 1.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 0.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 1.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 3.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 1.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 1.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 1.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 0.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 0.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 4.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 8.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 0.8 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 0.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 0.8 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.3 | 0.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 1.1 | GO:0034547 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 2.5 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 1.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 0.8 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 0.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 3.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 1.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 1.6 | GO:0034809 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.3 | 0.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 1.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 2.7 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 1.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 1.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 0.8 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.6 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 0.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 4.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 9.6 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.3 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 0.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 0.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 2.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 1.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 2.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.3 | 2.0 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.3 | 0.5 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 2.3 | GO:0034891 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 1.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 8.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 5.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 2.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 2.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 1.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 6.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 1.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 1.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 1.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 2.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 2.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.7 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.2 | 2.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 1.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 1.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 0.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 3.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 1.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 0.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 2.2 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 0.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 1.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 3.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 1.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 3.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 1.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 1.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 0.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.9 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 1.1 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.9 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 2.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.6 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 1.7 | GO:0034783 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 1.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 1.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 1.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 1.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 1.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.6 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 2.5 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.2 | 2.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.2 | 0.6 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 7.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 4.1 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 1.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 2.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 0.4 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.2 | 4.4 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 0.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 4.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.6 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.2 | 1.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 1.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 2.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 5.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 2.9 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.6 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 1.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 1.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 1.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 0.6 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 3.0 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 0.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 0.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 3.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 1.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 5.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 1.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 1.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 1.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 1.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 2.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 1.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 6.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 0.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 0.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 3.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 2.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 1.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 1.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 2.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 1.0 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.7 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 1.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 1.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 29.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 0.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 1.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 0.7 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 1.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 8.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 1.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 1.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.2 | 1.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.5 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 0.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 1.0 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 0.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 2.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.8 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 1.7 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 1.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 1.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 1.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 1.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 3.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 2.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 1.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 4.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.3 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 1.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 1.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 1.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 1.6 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 6.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 2.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 4.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 2.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 2.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 1.5 | GO:0034571 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 0.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 2.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 5.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 23.0 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 2.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.5 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.5 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 1.0 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.1 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 1.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 1.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.3 | GO:0051379 | epinephrine binding(GO:0051379) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 4.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 1.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 1.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.9 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 5.1 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 2.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 2.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 1.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 5.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 5.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 2.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.5 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 1.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.5 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 1.0 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 1.4 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.1 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 11.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.0 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 1.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 2.7 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.1 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 1.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 1.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 27.3 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 1.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 6.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 2.6 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 18.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 3.6 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 2.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.4 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 1.5 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.6 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 2.1 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 1.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 5.6 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 2.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.4 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 2.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.3 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 4.3 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 4.0 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 1.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) MutSalpha complex binding(GO:0032407) |
0.1 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 13.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 1.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 4.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 1.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.2 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.8 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 1.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 1.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.5 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 2.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 1.7 | GO:0004601 | peroxidase activity(GO:0004601) |
0.1 | 16.1 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 3.5 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 5.7 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 2.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.6 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 1.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 1.4 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.1 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 32.9 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.1 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.3 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.6 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.3 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.1 | 0.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.1 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.1 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 1.1 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 0.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 3.5 | GO:0016874 | ligase activity(GO:0016874) |
0.1 | 0.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 1.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.4 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.0 | 0.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.5 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.6 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.0 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 4.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 1.0 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 2.5 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 1.7 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.6 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.0 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 3.3 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 1.0 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 0.3 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 1.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.0 | 0.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 2.7 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 1.3 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.0 | 0.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.4 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.0 | 0.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.0 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.0 | GO:0035240 | dopamine binding(GO:0035240) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 8.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 3.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 2.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.4 | 3.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 13.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 6.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 3.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 11.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 2.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.4 | 4.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 13.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 15.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 15.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 6.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 2.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 4.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 2.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 4.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 8.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 4.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 5.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 1.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 11.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 6.3 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 1.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 1.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 5.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 4.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 1.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 11.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 1.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 5.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 4.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 5.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 1.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 3.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 7.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 1.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 4.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 3.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 3.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 6.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 1.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 2.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 3.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 3.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 2.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 7.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 9.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 5.9 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 3.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 2.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 3.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 1.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 4.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 1.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 1.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 6.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 2.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 6.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 2.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 4.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 2.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 2.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 1.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 1.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 0.9 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 2.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 3.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 1.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 1.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 5.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 2.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 2.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 4.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 2.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 2.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 0.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 2.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 1.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 3.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 2.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.2 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 3.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.0 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.8 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 2.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 2.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 11.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 4.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 5.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.3 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.5 | 1.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.5 | 4.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.5 | 2.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 7.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 5.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 7.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.5 | 0.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.5 | 15.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 6.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.5 | 7.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 5.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 4.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 4.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 5.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 7.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 3.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 4.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.4 | 7.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 9.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.4 | 15.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.4 | 4.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 5.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 6.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 6.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 2.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 3.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 6.6 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 1.6 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 10.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 8.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 2.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 3.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 4.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 29.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 5.1 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.3 | 1.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 2.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 4.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 1.7 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.3 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 1.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 1.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 0.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 5.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.3 | 3.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 3.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 8.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 2.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 2.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 1.8 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 5.2 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.3 | 1.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 2.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 2.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 9.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 1.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 4.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 1.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.2 | 1.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 1.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 4.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 6.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 2.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 1.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 3.2 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.2 | 5.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 2.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 2.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 1.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 1.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 4.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 1.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 2.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 9.4 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 0.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 4.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 2.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 16.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 8.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 0.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 2.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 2.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 3.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 1.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 1.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 1.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 11.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 2.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 1.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 3.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 7.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 7.5 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.2 | 0.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 3.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 2.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 4.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 2.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 3.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 2.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 3.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 4.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 2.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 2.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 4.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 3.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 1.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.9 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 2.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 6.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.4 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 1.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 6.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 10.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 3.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 12.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 5.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 2.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 2.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 3.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 2.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.6 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 1.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 2.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.0 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 0.2 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.1 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 4.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.0 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.7 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.0 | 0.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 1.0 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.7 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 2.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 1.6 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |